21171 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
#2haNK Cetuximab Combinations And Methods
#3TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#4GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES
#5COMPOSITIONS, KITS, METHODS, AND METHODS OF ADMINISTRATION RELATING TO EDWARDSIELLA PISCICIDA VACCINE AND/OR ANTIGEN DELIVERY VECTOR SYSTEMS
#6RECOMBINANT VECTOR FOR EXPRESSING IMMUNOGENIC PROTEIN OF PORCINE EPIDEMIC DIARRHEA VIRUS (PEDV), RECOMBINANT STRAIN INCLUDING THE SAME, AND USE THEREOF
#7DUAL-PROMOTER RECOMBINANT VECTOR EXPRESSING IMMUNOGENIC PROTEIN OF AFRICAN SWINE FEVER VIRUS (ASFV), RECOMBINANT BACTERIUM, AND USE THEREOF
#8STREPTOCOCCAL VACCINES AND METHODS FOR USE
#9ENHANCED EXPRESSION VIA AUTOTRANSPORTERS
#10CANCER IMMUNOTHERAPY ORAL VACCINE
#11LIPOPOLYSACCHARIDE (LPS) DEFICIENT ACINETOBACTER BAUMANNII MULTIVALENT VACCINE
#12ANTI-GUCY2C VACCINES AND VACCINATION
#13CHIMERIC ZIKA VIRUS ANTICANCER VACCINE OBTAINED THROUGH BREAST CANCER CELL PASSAGE
#14RECOMBINANT ATTENUATED SALMONELLA VACCINES (RASVS) AGAINST INFECTIONS BY AVIAN PATHOGENIC ESCHERICHIA COLI (APEC)
#15TREATMENT OF CANCER USING MRNA-MEDIATED VIRUS VACCINATION ANTIGENS DELIVERED BY ATTENUATED BACTERIA
#16GENE DELIVERY SYSTEM
#17Method for Preparing Outer Membrane Vesicles
#18COMPOSITIONS AND METHODS
#19Engineered Probiotic Delivery System for Anti-SARS-COV-2 Treatment and Immunity Against Viruses
#20COMPOSITIONS OF VACCINES AGAINST CLOSTRIDIAL DERMATITIS AND METHODS OF USE THEREOF
#21ANTIGEN DELIVERING SALMONELLA FOR USE AS A TUMOR HOMING BEACON TO REFOCUS PREEXISTING, VACCINE GENERATED T CELLS TO COMBAT CANCER
#22VACCINATION AND ANTIBODY GENERATION PLATFORM
#23METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#24NOVEL LIVE MULTI-ANTIGENIC RECOMBINANT VACCINE AGAINST TUBERCULOSIS
#25COMPOSITIONS COMPRISING RECOMBINANT STRAINS OF MYCOBACTERIUM, USES THEREOF AND METHODS FOR THE PREVENTION AND/OR TREATMENT OF CANCER
#26PROBIOTIC VACCINES AND RELATED METHODS OF USE
#27A Novel Poultry Salmonella Vaccine and Diagnostic Methodology to Control Foodborne Salmonellosis
#28Listeria Variants and Methods of Use Thereof
#29Attenuated Bordetella Strains
#30Vaccines targeting Neisseria gonorrhoeae
#31METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING MALARIA
#32SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#33COMPOSITIONS AND METHODS FOR TREATMENT OF CANCER USING BACTERIA
#34Foot and Mouth Disease Virus (FMDV) Consensus Proteins, Coding Sequences Therefor and Vaccines Made Therefrom
#35METHOD OF PRODUCING AN IMMUNOGENIC COMPOSITION
#36Combination Immunotherapy Compositions Against Cancer and Methods
#37ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT INFECTION FROM A PATHOGEN
#38PROTECTIVE IMMUNITY ENHANCED ATTENUATED SALMONELLA VACCINE (PIESV) VECTOR SYSTEMS
#39GUT BACTERIA DERIVED MICROVESICLES FOR VACCINE DELIVERY
#40Novel anti-cancer vaccine composition and a method of vaccination using the same
#41NOVEL CORONAVIRUS VACCINE BASED ON CONTROLLABLE SECRETORY EXPRESSION OF ATTENUATED SALMONELLA, PREPARATION METHOD THEREFOR, AND APPLICATION THEREOF
#42SUBUNIT VACCINE DELIVERY PLATFORM FOR ROBUST HUMORAL AND CELLULAR IMMUNE RESPONSES
#43Recombinant Mycobacterium as an Immunotherapeutic Agent for the Second-Line Therapy of Bladder Carcinoma
#44COMPOSITIONS AND METHODS FOR INDUCING IMMUNE RESPONSES AGAINST CLASS I FUSION PROTEIN VIRUSES
#45GENETICALLY MODIFIED CLOSTRIDIUM STRAINS EXPRESSING RECOMBINANT ANTIGENS AND USES THEREOF
#46ORAL VACCINE VIA DENTAL BACTERIA AND EMITTED PEPTIDES TO PREVENT COVID-19 INFECTION
#47MODIFIED MENINGOCOCCAL FHBP POLYPEPTIDES
#48AUTOTRANSPORTER SYSTEM
#49SLAM polynucleotides and polypeptides and uses thereof
#50VACCINE COMPOSITION COMPRISING A LEISHMANIA HOST CELL EXPRESSING AT LEAST ONE PROTEIN OF THE FAMILY CORONAVIRIDAE
#51NOVEL RECOMBINANT STRAIN OF MYCOBACTERIUM SMEGMATIS AND USE OF SAME
#52COMPOSITIONS AND METHODS FOR TREATING AND PREVENTING HUMAN CHLAMYDIAL INFECTIONS AND DISEASES USING ATTENUATED ANIMAL CHLAMYDIA
#53LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS HETEROLOGOUS OUTER MEMBRANE PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#54MICROORGANISM DISPLAYING ANTIGENIC PROTEIN OF THE SARS-CoV2 CORONAVIRUS
#55IMMUNOGENIC COMPOSITIONS TARGETING RECURRENT CANCER MUTATIONS AND METHODS OF USE THEREOF
#56IMMUNOSTIMULATORY BACTERIA FOR THE TREATMENT OF CANCER
#57OPTIMIZED HOST/VECTOR SYSTEM FOR PRODUCING PROTECTIVE MONO- AND MULTIVALENT SUBUNIT VACCINES ON THE BASIS OF THE YEAST KLUYVEROMYCES LACTIS
#58ORAL CORONAVIRUS INFECTION VACCINE
#59RECOMBINANT BACTERIUM AND USES THEREOF
#60Compositions and methods for the treatment of type 1 diabetes
#61Vaccine Composition for Preventing Tuberculosis Comprising Chorismate Mutase
#62Targeted neoepitope vectors and methods therefor
#63GENETICALLY MODIFIED BACTERIA FOR GENERATING VACCINES
#64HIGH DOSE SHIGELLA VACCINE PREPARATION
#65LISTERIA-BASED COMPOSITIONS COMPRISING A PEPTIDE MINIGENE EXPRESSION SYSTEM AND METHODS OF USE THEREOF
#66BACTERIAL AND VIRAL VACCINE STRATEGY
#67ACTINOBACILLUS PLEUROPNEUMONIAE VACCINES
#68Genetically engineered live bacteria and methods of constructing the same
#69ORAL RECOMBINANT YEAST FOR EXPRESSING S PROTEIN OF NOVEL CORONAVIRUS, PREPARATION THEREFOR, AND APPLICATION THEREOF
#70Compositions and methods of enhancing immune responses
#71LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS CANCER PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#72Southern cattle tick vaccine product
#73MONOCYTES INDUCING ANTIGEN-SPECIFIC TOLERANCE, ENGINEERED MONOCYTES, AND METHOD OF USE THEREOF
#74COMPOSITIONS AND METHODS FOR VACCINATION AGAINST NEISSERIA GONORRHOEAE
#75Combination immunotherapy compositions against cancer and methods
#76ENGINEERED BACTERIA FOR USE IN VACCINE COMPOSITIONS
#77NOVEL USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A HUMAN RESPIRATORY SYNCYTIAL VIRUS PROTEIN AGAINST bRSV IN CATTLE
#78RECOMBINANT BACTERIA FOR USE AS A VACCINE TO PREVENT COVID19 INFECTION
#79SAFE POTENT SINGLE VECTOR PLATFORM VACCINE AGAINST COVID-19
#80WT1 TARGETING DNA VACCINE FOR COMBINATION THERAPY
#81YEAST-BASED VACCINES
#82NOVEL SALMONELLA-BASED CORONAVIRUS VACCINE
#83IMMUNOTHERAPEUTIC MODULATION OF AMYLOIDOGENIC DISEASE USING NON-FIBRILLOGENIC, NON-AMYLOIDOGENIC POLYMERIZED PROTEINS AND PEPTIDES
#84SALMONELLA-BASED DNA VACCINES IN COMBINATION WITH AN ANTIBIOTIC
#85METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#86LIVE SALMONELLA TYPHI VECTORS ENGINEERED TO EXPRESS PROTEIN ANTIGENS AND METHODS OF USE THEREOF
#87ATTENUATED SALMONELLA SYNTHESIZING ANTIGENS FOR VACCINATING AGAINST HELICOBACTER PYLORI
#88RECOMBINANT BCG, PREPARATION METHOD THEREFOR AND APPLICATION THEREOF
#89NEW USE OF BCG IMMUNOGENIC FORMULATION EXPRESSING A RESPIRATORY SYNCITIAL VIRUS PROTEIN AGAINST hMPV
#90CONDITIONALLY REPLICATING M. BOVIS BCG
#91Nant Cancer Vaccine
#92haNK Cetuximab Combinations And Methods
#93Method of producing an immunogenic composition
#94BACTERIA-ENGINEERED TO ELICIT ANTIGEN-SPECIFIC T-CELLS
#95LIVE ATTENUATED ORAL VACCINE AGAINST SHIGELLOSIS AND TYPHOID FEVER
#96COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF PRION DISEASE
#97Compositions and methods of enhancing immune responses to or limiting infection
#98Novel PD-L1 Targeting DNA Vaccine for Cancer Immunotherapy
#99A PORCINE CIRCOVIRUS TYPE 2 (PCV2) VACCINE
#100Compositions and methods of enhancing immune responses
#101IMMUNOMODULATION PLATFORM AND METHODS OF USE
#102Compositions and methods for regulation of chronic toxoplasma infection
#103LIVE ATTENUATED ORAL VACCINE AGAINST COVID-19 AND TYPHOID FEVER
#104Yeast-Based Oral Vaccination
#105IMMUNOSTIMULATORY BACTERIA-BASED VACCINES, THERAPEUTICS, AND RNA DELIVERY PLATFORMS
#106COMPOSITIONS AND VACCINES FOR TREATING AND/OR PREVENTING VIRAL INFECTIONS, AND METHODS OF USING THE SAME
#107Gut bacteria derived microvesicles for vaccine delivery
#108Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#109Process for the production of a DNA vaccine for cancer immunotherapy
#110Protective immunity enhanced vaccine (PIESV) against spp
#111Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#112Live self-destructing bacterial adjuvants to enhance induction of immunity
#113Vsg-based vaccination and antibody generation platform for the treatment of diseases
#114TUMOR HLA MUTATION VERSUS MATCHED NORMAL HLA
#115COMPOSITIONS AND METHODS FOR PREVENTING AND TREATING VIRUS INFECTION
#116SLAM polynucleotides and polypeptides and uses thereof
#117Tuberculosis compositions and methods of using the same
#118SURFACE DISPLAY OF PROTEINS ON RECOMBINANT BACTERIA AND USES THEREOF
#119Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#120Nant cancer vaccine
#121Non-integrative listeria-based vaccine and method for inducing antitumor immune response
#122IMMUNE MODIFYING PARTICLES FOR THE TREATMENT OF CANCER
#123Induction of protective immunity against antigens
#124Food safety vaccine to control and reduce in poultry
#125Southern cattle tick vaccine product
#126Modified meningococcal fHbp polypeptides
#127Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#128Optimized host/vector system for producing protective mono- and multivalent subunit vaccines on the basis of the yeast
#129Recombinant BCG expressing HIV-1 p24 using pMyong2 vector system and use thereof
#130NEOANTIGEN TARGETING DNA VACCINE FOR COMBINATION THERAPY
#131Parasite vaccine
#132Compositions comprising recombinant probiotic bacteria and methods of use thereof
#133Method of manufacturing dual specific T-cells for use in cancer immunotherapy
#134IMMUNOGENIC HETEROCLITIC PEPTIDES FROM CANCER-ASSOCIATED PROTEINS AND METHODS OF USE THEREOF
#135Streptococcal vaccine
#136MULTIEPITOPE FUSION ANTIGENS FOR VACCINATION AND METHODS OF MAKING AND USING SUCH ANTIGENS
#137Compositions and methods for the treatment of type 1 diabetes
#138Combination immunotherapy compositions against cancer and methods
#139VEGFR-2 TARGETING DNA VACCINE FOR COMBINATION THERAPY
#140Combination immunotherapy compositions against cancer and methods
#141Method for reducing zoonotic infectious diseases
#142Compositions and methods of enhancing immune responses to eimeria or limiting eimeria infection
#143Mucosal adjuvants and delivery systems
#144Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#145Live attenuated oral vaccine against ETEC and typhoid fever
#146Induction of protective immunity against antigens
#147Improved Yeast Polytope Vaccine Compositions And Methods
#148Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and human
#149Immunogenic RSV polypeptides
#150Immunogenic sequences from a phage tail length tape measure protein, bacteria expressing the same and their use in treating a cancer
#151Campylobacter immunogenic compositions and uses thereof
#152Compositions and methods of enhancing immune responses to enteric pathogens
#153Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#154Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#155HaNK cetuximab combinations and methods
#156COMPOSITIONS COMPRISING RECOMBINANT PROBIOTIC BACTERIA AND METHODS OF USE THEREOF
#157Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
#158METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#159Yeast-Based Immunotherapy for Tumour Prevention
#160Surface display of antigens on Gram-negative outer membrane vesicles
#161Compositions and methods for the therapy and diagnosis of Inflammatory Bowel Disease
#162Recombinant mycobacterium as an immunotherapeutic agent for the treatment of cancer
#163Live vectors engineered to express heterologous outer membrane protein antigens and methods of use thereof
#164Attenuated strains
#165Nant cancer vaccine
#166Regulated expression of antigen and/or regulated attenuation to enhance vaccine immunogenicity and/or safety
#167Modified gram positive bacteria and uses thereof
#168Compositions and methods for tumor vaccination and immunotherapy involving HER antigens
#169Mesothelin vaccines and model systems
#170Subunit vaccine delivery platform for robust humoral and cellular immune responses
#171PD-L1 targeting DNA vaccine for cancer immunotherapy
#172Compositions and methods comprising KLK3 or FOLH1 antigen
#173Combination immunotherapy compositions against cancer and methods
#174COMBINATION OF LISTERIA-BASED VACCINE WITH ANTI-CTLA-4 OR ANTI-CD137 ANTIBODIES
#175Targeted neoepitope vectors and methods therefor
#176VEGFR-2 targeting immunotherapy approach
#177Virulent vaccines and methods
#178Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vaccines made therefrom
#179Food safety vaccine to control and reduce campylobacter in poultry
#180Induction of protective immunity against antigens
#181PERSONALIZED DELIVERY VECTOR-BASED IMMUNOTHERAPY AND USES THEREOF
#182Coordinated multi-prong cancer therapy
#183PHARMACEUTICAL TREATMENTS FOR PREVENTING OR TREATING PANCREATIC CANCER
#184Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#185Compositions and methods of enhancing immune responses to enteric pathogens
#186Cancer therapy utilizing combination of oral tumor vaccine and immunosuppression inhibitor
#187Immunotherapeutic modulation of amyloidogenic disease using non-fibrillogenic, non-amyloidogenic polymerized proteins and peptides
#188Immunogenic compositions targeting recurrent cancer mutations and methods of use thereof
#189Tuberculosis compositions and methods of using the same
#190Modified meningococcal FHBP polypeptides
#191Meningococcal infection and modified
#192Method for preventing or treating infection
#193Compositions and methods for treatment of cancer using bacteria
#194Edible vaccines expressed in yeast for preventing and treating infectious diseases, including hepatitis B, in humans
#195Edible vaccines expressed in yeast for preventing and treating infectious diseases in animals and humans
#196Compositions and methods of enhancing immune responses to or limiting infection
#197Immunomodulator for hypersensitivity reaction to house dust mite-derived allergen
#198Safe potent single platform vaccine against Tier 1 select agents and other pathogens
#199RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF PRODUCING THE SAME
#200Mucosal adjuvants and delivery systems
#201Yeast-MUC1 immunotherapeutic compositions and uses thereof
#202Hepatitis B treatment vaccine on the basis of inactivated, whole recombinant Hansenula polymorpha cells expressing HBsAg
#203Processing engineered FMDV P1 polypeptide using an alternative TEV protease
#204Protective anti-ZIKV vaccine without inducing cross-reactions with dengue
#205DEVELOPMENTS IN MENINGOCOCCAL OUTER MEMBRANE VESICLES
#206Process for the production of a DNA vaccine for cancer immunotherapy
#207Attenuated strains
#208Compositions and methods for the treatment or prevention of tuberculosis
#209Immunogenic Compositions and Vaccines Derived From Bacterial Surface Receptor Proteins
#210Compositions comprising angiogenic factors and methods of use thereof
#211SLAM polynucleotides and polypeptides and uses thereof
#212Recombinant Hansenula polymorpha-based high dosage hepatitis B vaccine
#213Production of recombinant vaccine in by enzymatic conjugation
#214Treatment of immune disease by mucosal delivery of antigens using genetically modified
#215METHOD OF INDUCING TOLERANCE TO AN ALLERGEN
#216Adhesin as immunogen against enterotoxigenic
#217Targets and compositions for use in decontamination, immunoprophylaxis, and post-exposure therapy against anthrax
#218Immunostimulatory bacteria for the treatment of cancer
#219Campylobacter immunogenic compositions and uses thereof
#220Method for preventing or treating infection
#221RECOMBINANT LISTERIA VACCINE STRAINS AND METHODS OF USING THE SAME IN CANCER IMMUNOTHERAPY
#222MODULATION OF YEAST-BASED IMMUNOTHERAPY PRODUCTS AND RESPONSES
#223Compositions and methods for the treatment of type 1 diabetes
#224Live bacterial vectors for prophylaxis or treatment
#225METHODS AND COMPOSITIONS USING LISTERIA FOR ENHANCING IMMUNOGENICITY BY PRIME BOOST
#226DNA vaccine for use in pancreatic cancer patients
#227Listeria-based compositions comprising a peptide minigene expression system and methods of use thereof
#228Targeted gene delivery to non-phagocytic mammalian cells via bacterially derived intact minicells
#229Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#230LISTERIA-BASED IMMUNOTHERAPY AND METHODS OF USE THEREOF
#231Lactic acid bacterium, drug, food or drink, and feed which contain the lactic acid bacterium
#232Method of manufacturing dual-specific T-cells for use in cancer immunotherapy
#233Recombinant lactic acid bacteria and the use thereof in oral universal influenza vaccine
#234Compositions and methods of enhancing immune responses to
#235MANUFACTURING DEVICE AND METHOD OF AN IMMUNOTHERAPEUTIC FORMULATION COMPRISING A RECOMBINANT LISTERIA STRAIN
#236Compositions and methods for the treatment or prevention of hepatitis B virus infection
#237Recombinant Mycobacterium Encoding A Heparin-Binding Hemagglutinin (HBHA) Fusion Protein And Uses Thereof
#238Anti-cancer vaccine combination
#239ENGINEERED LISTERIA AND METHODS OF USE THEREOF
#240Live attenuated oral vaccine against shigellosis and typhoid fever
#241Bacillus based delivery system and methods of use
#242VEGFR-2 targeting DNA vaccine for combination therapy
#243Modified gram positive bacteria and uses thereof
#244BACTERIAL AND VIRAL VACCINE STRATEGY
#245Modified yeast-brachyury immunotherapeutic compositions
#246Processing of a modified foot-and-mouth disease virus P1 polypeptide by an alternative protease
#247Recombinant as an immunotherapeutic agent for the treatment of cancer
#248Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#249COMBINATION OF A PD-1 ANTAGONIST AND A LISTERIA-BASED VACCINE FOR TREATING PROSTATE CANCER
#250Chimeric proteins
#251Involucrin-driven retroviral expression cassettes encoding human immunodeficiency virus envelope glycoproteins
#252Compositions and methods of enhancing immune responses to or limiting infection
#253Oral cancer vaccine
#254Salmonella-based vectors for cancer immunotherapy targeting Wilms' tumor gene WT1
#255NOVEL CMV PP65 TARGETING DNA VACCINE FOR CANCER IMMUNOTHERAPY
#256Surface display of antigens on gram-negative outer membrane vesicles
#257Compositions and methods for the therapy and diagnosis of inflammatory bowel disease
#258HIV immune stimulating compositions comprising recombinantly expressed pili on bacteria and methods related thereto
#259Streptococcal vaccine
#260Immunogenic RSV polypeptides
#261Immunogenic Listeria-Based Compositions Comprising Truncated Acta-Antigen Fusions And Methods Of Use Thereof
#262Vaccine for prophylaxis or treatment of an allergen-driven airway pathology
#263Immunogenic Fusion Proteins For The Treatment Of Cancer
#264Subunit vaccine delivery platform for robust humoral and cellular immune responses
#265MSLN targeting DNA vaccine for cancer immunotherapy
#266with an O-antigen having an extended carbohydrate chain and use thereof
#267COMPOSITION AND USES THEREOF
#268METHODS AND COMPOSITIONS FOR INDUCING AN IMMUNE RESPONSE TO EGFRVIII
#269Compositions comprising recombinant probiotic bacteria and methods of use thereof
#270ENGINEERED LISTERIA AND METHODS OF USE THEREOF
#271Attenuated bacteria and methods of using
#272Cyclic di-AMP induction of type I interferon
#273Yeast vaccine vector including immunostimulatory and antigenic polypeptides and methods of using the same
#274GENETICALLY MODIFIED BABESIA PARASITES EXPRESSING PROTECTIVE TICK ANTIGENS AND USES THEREOF
#275Attenuated Bordetella strains
#276Methods for constructing antibiotic resistance free vaccines
#277rDNA NTS-based gene multiple insertion cassette set and GRAS-grade recombinant yeast strain
#278Multivalent vaccine for protection against mycobacterial infections and methods of using the same
#279RECOMBINANT LISTERIA STRAIN EXPRESSING HETEROLOGOUS ANTIGEN FUSION PROTEINS AND METHODS OF USE THEREOF
#280Yeast-MUC1 immunotherapeutic compositions and uses thereof
#281Bacterial vaccines deficient in the 2-C-methyl-D-erythritol-4-phosphate pathway and methods of preparation and use thereof
#282Animal models, cell lines and methods for screening hepatitis C virus vaccines
#283Methods of Transforming a Listeria
#284Method for preventing or treating infection
#285Yeast-based compositions and methods for the treatment or prevention of hepatitis delta virus infection
#286Compositions and methods of enhancing immune responses to or limiting infection
#287Composition and method for reducing zoonotic infectious diseases
#288Recombinant Bacterium and Uses Thereof
#289VACCINE
#290Immunotherapy composition and use thereof
#291Live bacterial vaccines resistant to carbon dioxide (CO), acidic pH and/or osmolarity for viral infection prophylaxis or treatment
#292Mucosal adjuvants and delivery systems
#293ATTENUATED AND ADAPTED STRAIN OF PSEUDOMONAS FOR DELIVERING ANTIGENS
#294Recombinant BCG expressing antigens of the ESX-1 secretion system
#295COMBINATORIAL IMMUNOTHERAPY FOR PANCREATIC CANCER TREATMENT
#296Induction of mucosal tolerance to antigens
#297COMPOSITIONS AND METHODS COMPRISING KLK3 OR FOLH1 ANTIGEN
#298METHODS AND COMPOSITIONS FOR INCREASING A T-EFFECTOR CELL TO REGULATORY T CELL RATIO
#299Mesothelin vaccines and model systems
#300Tumor vaccination involving a humoral immune response against self-proteins